临床试验/NCT05791838

NCT05791838尚未招募不适用

Borderline Ovarian Tumors: Results of a Retrospective, Single-center Experience

University of Palermo0 个研究点目标入组 86 人开始时间: 2023年3月最近更新: 2023年3月30日

适应症

试验速览

阶段: 不适用
状态: 尚未招募
发起方: University of Palermo
入组人数: 86
主要终点: Oncological outcome

研究概览研究设计入排标准结局指标研究者记录与标识符相似试验

研究概览

简要总结

Borderline ovarian tumors (BOTs) comprise 15-20% of primary ovarian neoplasms and represent an independent disease entity among epithelial ovarian cancers. The present study aimed to report the 8-year experience of a single center on the management and outcomes of consecutive BOTs patients. From January 2010 to December 2017, all patients with BOTs undergoing surgical treatment were included. Demographic, clinical, and pathological data were reviewed retrospectively.

研究设计

研究类型: Observational
观察模型: Cohort
时间视角: Retrospective

入排标准

年龄范围: 18 Years 至 —（Adult, Older Adult）
性别: Female
接受健康志愿者: 否

入选标准

•Age > 18 years,
•Patients affected by borderline ovarian tumors (BOT) of any histological type and any FIGO stage,
•Women undergoing surgical treatment with both laparoscopic and laparotomic approaches.

排除标准

•Women affected by ovarian cancers

结局指标

主要结局

Oncological outcome

时间窗: through study completion, an average of 1 year

Patients who underwent surgery for BOT

次要结局

未报告次要终点

研究者

发起方

University of Palermo

申办方类型

Other

责任方

Principal Investigator

主要研究者

Andrea Etrusco

Principal investigator

University of Palermo

相似试验

招募中

不适用

A Prospective Multicenter Diagnostic Biomarker Study to Discriminate Borderline From Stage I Invasive Ovarian CancerStage I Ovarian CancerBorderline Ovarian Tumors

NCT06709872KU Leuven400

已完成

不适用

Prospective Multicenter Study in Patients With a Tumor Benign Ovarian Presumed on the Use of Algorithms Such as Roma and RMI and Tumor Markers Such as CA125 and HE4Ovarian CancerOvarian Tumor

NCT02326064Centre Hospitalier Departemental Vendee221

已完成

不适用

Ovarian Clear Cell Adenocarcinoma ReviewOvarian Cysts

NCT02129036Cathay General Hospital5

招募中

不适用

SEQUENTIAL PROFILING OF TUMOR-DERIVED CIRCULATING CELL-FREE DNA (ctDNA) IN ADVANCED OVARIAN CANCER PATIENTSOvarian Cancer

NCT06071286Fondazione Policlinico Universitario Agostino Gemelli IRCCS30

已完成

不适用

Benign Reproductive Tissue Analysis for Endometrial Cancer MarkersOophorectomy for Benign ReasonsHysterectomy

NCT00481754National Cancer Institute (NCI)359